edited by Julian Bogousslavsky
Thrombolytic and Antithrombotic Therapy for Stroke contains authoritative information in an easy to use format.
Features:
- Presents personal perspectives from a hand-picked panel of experts
- Provides an overview of antithrombotic/thrombolytic clinical trials in cardiology
- Explores new antithrombotics and their potential use
Contents
- History of Antithrombotic Treatment in Stroke
- Antiplatelet Agents
- Anticoagulants
- Fibrinolytics
- The Vessel Wall in Thrombosis
- Thrombus Formation and Resolution
- Thrombosis, Atherothrombosis, Thromboembolism in Etiology of Stroke
- Antithrombotic/thrombolytic Clinical Trials in Cardiology: An Overview
- Study Design for Antithrombotic Treatment Trials in Stroke: Mistakes and Lessons
- Heparin, Heparinoids, Low-molecular Weight Heparin in Acute Stroke
- Aspirin in Acute Stroke
- GpIIb/IIIa Inhibitors in Acute Stroke
- New Antithrombotics and Their Potential Use
- Fibirin Degradating Drugs in Acute Stroke
- Intravenous Thrombolysis: The Studies and the Facts
- Complications of Thrombolysis
- New Analyses of ECASS and NINDS
- The Implementation of Thrombolytic Treatment for Stroke in Routine Practice
- Imaging Brain Tissue Salvage from Brain Reperfusion
- To Select or Not Select. IA Thrombolysis
- Ultrasound-enhanced Lysis
- Various Combined Approaches: Present and Future
- Antithrombotic Therapy and Stenting
- Antithrombotic and Thrombolytic Treatment in Cerebral Venous Thrombosis, Arterial Dissection and Special Conditions
- The Role of Thrombolytics in Hemorrhagic Stroke
Index